Catalyst
Slingshot members are tracking this event:
Five Prime Therapeutics (FPRX) to complete Phase 1 Single and Multiple Dose Study of FPA008 in Healthy Volunteers and Rheumatoid Arthritis Subjects in late 2016 to early 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| FPRX |
|
|
||||
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 14, 2016
Occurred Source:
https://clinicaltrials.gov/archive/NCT01962337/2016_09_14/changes
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1 Study, Fpa 008, Rheumatoid Arthritis
